目的：建立新新肝康片的质量标准。
OBJECTIVE:To set up the quality standards for Xinxin Gankang tablet(XXGK).
目的：制备益肝康口服液并建立其质量标准。
OBJECTIVE: To prepare Yigankang oral liquid and establish its quality criteria.
目的对解酒肝康颗粒的提取工艺进行正交设计研究。
Objective To study the extraction process of Jiejiu Gankang granules by orthogonal test.
目的：研究肝康灵胶囊(GKL)对化疗药物的增效减毒作用。
OBJECTIVE: To investigate the synergy and attenuation action of Gankangling capsules (GKL) on chemotherapeutics.
动物实验研究亦表明，脂肝康胶囊有明显的降脂、保肝等作用。
The animal experiments show that Zhigankang Capsule could reduce enzyme and protect liver, etc.
结论：本研究方法能快速准确地进行解酒肝康颗粒组成药物的定性检测、鉴别。
Conclusion: the research method contributes to the qualitative detection and differentiation of Jiejiu Gankang Granules in an efficient and accurate way.
用鸭乙型肝炎（乙肝）模型研究肝康栓抗鸭乙型肝炎病毒（DHBV）和改善肝脏病理的作用。
To study the antiviral effect of Gankang suppository(GS) on duck hepatitis B virus(DHBV) in vivo, and observe the changes of hepatic pathology.
目的：探讨糖尿病性脂肪肝与胰岛素抵抗的关系以及中药糖肝康对糖尿病性脂肪肝胰岛素抵抗的防治作用。
Objective: to explore the relation between insulin resistance and diabetic fatty liver and to study the prophylaxis and treatment of diabetic fatty liver with Tang Gan Kang (TGK).
目的：建立肝脾康颗粒的质量标准。
Objective: To establish the quality standard for Ganpikang granules.
目的探讨脂肪肝患者是否存在胰岛素抵抗（IR），并评价血脂康对其干预效果。
Objective To investigate whether fatty liver disease is associated with insulin resistance(IR), and to evaluate the effect of Xuezhikang intervention for these patients.
目的：研究肝乐康胶囊抗肝纤维化的作用。
Objective: To investigate the anti-hepatic fibrosis action of Ganlekang Capsule.
目的：利疸康颗粒治疗药物性肝损伤内毒素水平的疗效探讨。
Objectives: To explore the efficiency of Lidankang Keli in treating Drug-induced liver injury.
结果甘泰康可有效对抗猪血清所致大鼠血清ha、LN、PCIII含量升高，有效对抗猪血清所致大鼠肝组织内胶原纤维、网状纤维增生。
Results Gantaikang could effectively counteract the increase of HA, LN and PCIII level in serum, and attenuate hepatic collagen and reticulin proliferation induced by porcine serum in rats.
目的：研究复康片预防卡马西平(CBZ)肝毒性的效果。
Aim: to study the preventive effect of Fukang tablet on liver toxicity induced by carbamazepine (CBZ).
且硬肝复康组HBV标志改善率、化验指标和临床症状改善率均明显高于对照组（P<0.05）。
The improvements of HBV marks, some indexes of clinical tests and clinical symptoms in GFK treated group were more remarkable than those in control group (P<0.05).
方法血管康袋泡茶给大鼠连续灌胃15d，观察大鼠肝组织血清中丙二醛(MDA)含量。
MethodsFeed mice of Xueguankang Tea for 15 days and observe the content of MDA in liver and serum.
说明利疸康颗粒有很好的治疗药物性肝损伤内毒素血症的作用。
All of above shows that Lidankang Keli has an good effect on curing Drug-induced liver injury.
肝复康对肝纤维化有疗效，其作用机制可能与降低肝组织JAK2和STAT3的表达，阻断JAK2/STAT3信号通路有关。
The mechanism of action may be related to the decreased expression of JAK2 and STAT3 of hepatic tissue and blocking of JAK2/STAT3 signal transduction pathway.
目的研究沙棘血脂康对高脂血症大鼠血脂和脂肪肝形成的防治作用。
OBJECTIVE To investigate the preventive role of Hippophae rhamnoides L. Xuezhikang at different concentrations on hyperlipidemia and fatty liver in rats.
临床研究肝脂康对非酒精性脂肪肝有满意确切的临床疗效。
The clinical study has pointed out that Ganzhikang has satisfying and exact curative effect on non-alcoholic fatty liver.
目的观察肝复康颗粒对大鼠慢性肝损伤模型的影响。
Objective To investigate the therapeutic effects of Ganfukang Granule(GFKG)on chronic liver injury induced by CCl 4 in rats.
模型组大鼠血脂、ALT较空白对照组和肝脂康组显著增高（P＜0.01）；
The blood-fat and ALT of the rats in the model group increased markedly compared with the blank control group (P<0.01);
模型组大鼠血脂、ALT较空白对照组和肝脂康组显著增高（P＜0.01）；
The blood-fat and ALT of the rats in the model group increased markedly compared with the blank control group (P<0.01);
应用推荐